Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo
D. L. Kober, M. C. Caballero Van Dyke, J. L. Eitson, I. N. Boys, M. B. McDougal, D. Rosenbaum, J. W. Schoggins
This paper develops a mutant ACE2 that neutralizes SARS-CoV-2 in vivo through aerosolized delivery, demonstrating its protective effect in a mouse model.
bioRxiv · Sep 26, 2023Microbiology